Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

11/02/2015 Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data 04/02/2015 Diarrhea: case definition and guidelines for collection, analysis, and presentation of immunization safety data 04/02/2015 Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety data 04/02/2015 Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study 30/09/2013 Better reporting of harms in randomized trials: an extension of the CONSORT Statement 21/06/2013 Anecdotes as evidence 20/06/2013 Recommendations for reporting adverse drug reactions and adverse events of traditional Chinese medicine 20/06/2013 Guidelines for submitting adverse event reports for publication

Blog archives

Latest guest blogger

  • Why did we develop TIDieR-Placebo?

    The TIDieR reporting guideline helps authors fully report their interventions, so that they can be used by others. However, TIDieR only explicitly covers active interventions, not placebo controls. The developers of the new TIDieR-Placebo extension explain why it is needed Read More